B-Secur recently received FDA clearance for its heart monitoring technology and hopes to expand its offering in the US market. Belfast-based health-tech company B-Secur has raised a total of £8.8m this year, attracting its first US investor in the process. Its latest round of funding was led by US-based First Capital Ventures, while Bank of Ireland’s growth fund Kernel Capital increased its investment in the company. Other existing investors also participated, including Co-Fund NI and Wharton Asset Management. The funds will be used to aid B-Secur’s expansion into the US.